Cargando…

Site-Specific (111)In-Radiolabeling of Dual-PEGylated Porous Silicon Nanoparticles and Their In Vivo Evaluation in Murine 4T1 Breast Cancer Model

Polyethylene glycol (PEG) has been successfully used for improving circulation time of several nanomaterials but prolonging the circulation of porous silicon nanoparticles (PSi NPs) has remained challenging. Here, we report a site specific radiolabeling of dual-PEGylated thermally oxidized porous si...

Descripción completa

Detalles Bibliográficos
Autores principales: Lumen, Dave, Näkki, Simo, Imlimthan, Surachet, Lambidis, Elisavet, Sarparanta, Mirkka, Xu, Wujun, Lehto, Vesa-Pekka, Airaksinen, Anu J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6969933/
https://www.ncbi.nlm.nih.gov/pubmed/31861119
http://dx.doi.org/10.3390/pharmaceutics11120686
_version_ 1783489413989269504
author Lumen, Dave
Näkki, Simo
Imlimthan, Surachet
Lambidis, Elisavet
Sarparanta, Mirkka
Xu, Wujun
Lehto, Vesa-Pekka
Airaksinen, Anu J.
author_facet Lumen, Dave
Näkki, Simo
Imlimthan, Surachet
Lambidis, Elisavet
Sarparanta, Mirkka
Xu, Wujun
Lehto, Vesa-Pekka
Airaksinen, Anu J.
author_sort Lumen, Dave
collection PubMed
description Polyethylene glycol (PEG) has been successfully used for improving circulation time of several nanomaterials but prolonging the circulation of porous silicon nanoparticles (PSi NPs) has remained challenging. Here, we report a site specific radiolabeling of dual-PEGylated thermally oxidized porous silicon (DPEG-TOPSi) NPs and investigation of influence of the PEGylation on blood circulation time of TOPSi NPs. Trans-cyclooctene conjugated DPEG-TOPSi NPs were radiolabeled through a click reaction with [(111)In]In-DOTA-PEG(4)-tetrazine (DOTA = 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) and the particle behavior was evaluated in vivo in Balb/c mice bearing 4T1 murine breast cancer allografts. The dual-PEGylation significantly prolonged circulation of [(111)In]In-DPEG-TOPSi particles when compared to non-PEGylated control particles, yielding 10.8 ± 1.7% of the injected activity/g in blood at 15 min for [(111)In]In-DPEG-TOPSi NPs. The improved circulation time will be beneficial for the accumulation of targeted DPEG-TOPSi to tumors.
format Online
Article
Text
id pubmed-6969933
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-69699332020-02-04 Site-Specific (111)In-Radiolabeling of Dual-PEGylated Porous Silicon Nanoparticles and Their In Vivo Evaluation in Murine 4T1 Breast Cancer Model Lumen, Dave Näkki, Simo Imlimthan, Surachet Lambidis, Elisavet Sarparanta, Mirkka Xu, Wujun Lehto, Vesa-Pekka Airaksinen, Anu J. Pharmaceutics Article Polyethylene glycol (PEG) has been successfully used for improving circulation time of several nanomaterials but prolonging the circulation of porous silicon nanoparticles (PSi NPs) has remained challenging. Here, we report a site specific radiolabeling of dual-PEGylated thermally oxidized porous silicon (DPEG-TOPSi) NPs and investigation of influence of the PEGylation on blood circulation time of TOPSi NPs. Trans-cyclooctene conjugated DPEG-TOPSi NPs were radiolabeled through a click reaction with [(111)In]In-DOTA-PEG(4)-tetrazine (DOTA = 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) and the particle behavior was evaluated in vivo in Balb/c mice bearing 4T1 murine breast cancer allografts. The dual-PEGylation significantly prolonged circulation of [(111)In]In-DPEG-TOPSi particles when compared to non-PEGylated control particles, yielding 10.8 ± 1.7% of the injected activity/g in blood at 15 min for [(111)In]In-DPEG-TOPSi NPs. The improved circulation time will be beneficial for the accumulation of targeted DPEG-TOPSi to tumors. MDPI 2019-12-17 /pmc/articles/PMC6969933/ /pubmed/31861119 http://dx.doi.org/10.3390/pharmaceutics11120686 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lumen, Dave
Näkki, Simo
Imlimthan, Surachet
Lambidis, Elisavet
Sarparanta, Mirkka
Xu, Wujun
Lehto, Vesa-Pekka
Airaksinen, Anu J.
Site-Specific (111)In-Radiolabeling of Dual-PEGylated Porous Silicon Nanoparticles and Their In Vivo Evaluation in Murine 4T1 Breast Cancer Model
title Site-Specific (111)In-Radiolabeling of Dual-PEGylated Porous Silicon Nanoparticles and Their In Vivo Evaluation in Murine 4T1 Breast Cancer Model
title_full Site-Specific (111)In-Radiolabeling of Dual-PEGylated Porous Silicon Nanoparticles and Their In Vivo Evaluation in Murine 4T1 Breast Cancer Model
title_fullStr Site-Specific (111)In-Radiolabeling of Dual-PEGylated Porous Silicon Nanoparticles and Their In Vivo Evaluation in Murine 4T1 Breast Cancer Model
title_full_unstemmed Site-Specific (111)In-Radiolabeling of Dual-PEGylated Porous Silicon Nanoparticles and Their In Vivo Evaluation in Murine 4T1 Breast Cancer Model
title_short Site-Specific (111)In-Radiolabeling of Dual-PEGylated Porous Silicon Nanoparticles and Their In Vivo Evaluation in Murine 4T1 Breast Cancer Model
title_sort site-specific (111)in-radiolabeling of dual-pegylated porous silicon nanoparticles and their in vivo evaluation in murine 4t1 breast cancer model
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6969933/
https://www.ncbi.nlm.nih.gov/pubmed/31861119
http://dx.doi.org/10.3390/pharmaceutics11120686
work_keys_str_mv AT lumendave sitespecific111inradiolabelingofdualpegylatedporoussiliconnanoparticlesandtheirinvivoevaluationinmurine4t1breastcancermodel
AT nakkisimo sitespecific111inradiolabelingofdualpegylatedporoussiliconnanoparticlesandtheirinvivoevaluationinmurine4t1breastcancermodel
AT imlimthansurachet sitespecific111inradiolabelingofdualpegylatedporoussiliconnanoparticlesandtheirinvivoevaluationinmurine4t1breastcancermodel
AT lambidiselisavet sitespecific111inradiolabelingofdualpegylatedporoussiliconnanoparticlesandtheirinvivoevaluationinmurine4t1breastcancermodel
AT sarparantamirkka sitespecific111inradiolabelingofdualpegylatedporoussiliconnanoparticlesandtheirinvivoevaluationinmurine4t1breastcancermodel
AT xuwujun sitespecific111inradiolabelingofdualpegylatedporoussiliconnanoparticlesandtheirinvivoevaluationinmurine4t1breastcancermodel
AT lehtovesapekka sitespecific111inradiolabelingofdualpegylatedporoussiliconnanoparticlesandtheirinvivoevaluationinmurine4t1breastcancermodel
AT airaksinenanuj sitespecific111inradiolabelingofdualpegylatedporoussiliconnanoparticlesandtheirinvivoevaluationinmurine4t1breastcancermodel